Responsibilities:
- Conduct patient intake and follow up consultations to evaluate ketamine-assisted psychotherapy (KAP) eligibility, prescribe, and monitor patient outcomes via telemedicine
- Suggest treatment plan changes based on patient response to medication and treatment outcomes
- Engage in collaborative care with Journey Clinical member psychotherapists
- Work with Journey Clinical care coordinator to streamline your workflow
- Continuously and promptly give honest feedback on the Journey Clinical care management system to improve our services
- Report directly to the Lead Clinician and collaborate with the leadership team and the co-founders
Profile:
- Licensed to practice in New York
- Minimum 1 year psych experience as a PMHNP
- DEA registration
- Comfortable prescribing controlled substances when medically appropriate
- Comfortable prescribing for anxiety and depression
- Ability to quickly synthesize medical and psychiatric information about the patient to formulate effective and evidence-based clinical recommendations
- Patient-first mindset, deep work ethic and dedication to the highest level of patient care
- Willing to use a few simple tools to make your life easier (Slack, G Suite, Zoom, etc.)
- Comfortable working remotely in a Telehealth fast-paced startup environment
- Interest for the field of psychedelic-assisted psychotherapy to transform mental health
What we offer:
- Competitive hourly or annual salary, equity (full time employees)
- Health benefits (for full time employees)
- Flexible working hoursFlexible paid time off (for full time employees)
- Ketamine-assisted psychotherapy (KAP) prescriber training and mentorship given by leading industry experts
- Growth opportunities and a high level of freedom
- We aim to set our team members up for success and offer a clear path for career advancement and personal growth
- Work with a team of industry leading experts, who are highly collaborative, disciplined, and who have fun working together
- The opportunity to change the way we approach mental health by advancing the mainstream adoption of psychedelic assisted psychotherapy and make a positive impact on the lives of 100M+ people who are suffering from depression and anxiety in the US today!